Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Emergent Biosolutions Inc (NYSE: EBS) closed at $5.50 in the last session, down -4.01% from day before closing price of $5.73. In other words, the price has decreased by -$4.01 from its previous closing price. On the day, 0.84 million shares were traded. EBS stock price reached its highest trading level at $5.73 during the session, while it also had its lowest trading level at $5.455.
Ratios:
We take a closer look at EBS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.35. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 3.69. In the meantime, Its Debt-to-Equity ratio is 1.40 whereas as Long-Term Debt/Eq ratio is at 1.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On August 22, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $16.
The Benchmark Company Upgraded its Hold to Buy on March 07, 2024, while the target price for the stock was maintained at $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fowler Neal Franklin sold 35,000 shares for $5.83 per share. The transaction valued at 204,050 led to the insider holds 101,100 shares of the business.
Zoon Kathryn C sold 10,000 shares of EBS for $57,300 on Mar 12 ’25. The Director now owns 44,482 shares after completing the transaction at $5.73 per share. On Mar 12 ’25, another insider, Fowler Neal Franklin, who serves as the Director of the company, bought 35,000 shares for $5.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 311351136 and an Enterprise Value of 887951168. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 0.62. Its current Enterprise Value per Revenue stands at 0.851 whereas that against EBITDA is 16.628.
Stock Price History:
The Beta on a monthly basis for EBS is 2.09, which has changed by 1.1235521 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.82. The 50-Day Moving Average of the stock is -33.88%, while the 200-Day Moving Average is calculated to be -37.11%.
Shares Statistics:
According to the various share statistics, EBS traded on average about 1.17M shares per day over the past 3-months and 1014570 shares per day over the past 10 days. A total of 54.30M shares are outstanding, with a floating share count of 52.32M. Insiders hold about 3.72% of the company’s shares, while institutions hold 63.92% stake in the company. Shares short for EBS as of 1740700800 were 8136737 with a Short Ratio of 6.96, compared to 1738281600 on 6925481. Therefore, it implies a Short% of Shares Outstanding of 8136737 and a Short% of Float of 18.180001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
